Kazia Therapeutics KZIA
NASDAQ KZIA
$6.62 -0.33 (-4.75%)
At close: Nov 13, 2026 · 4:00 PM EST

Kazia Therapeutics (KZIA) Share-based Compensation (2009 - 2020)

Updated

Kazia Therapeutics' Share-based Compensation was $423,228 in FY2025 (year ended Jun 30, 2025).

Analysis

Kazia Therapeutics (KZIA) Share-based Compensation (2009 - 2020) Analysis & Trends

From FY2009 onward, Kazia Therapeutics has reported Share-based Compensation for 15 fiscal years.

  • Share-based Compensation shows a five-year compound annual growth rate of 18.5% (FY2020 to FY2025).
  • Annual Share-based Compensation has moved between $351,832 (FY2024) and $1.16 million (FY2022) over five years.
  • Per Business Quant data, Share-based Compensation in earlier fiscal years was $351,832 in FY2024 (-54.3%), $770,270 in FY2023 (-33.8%), $1.16 million in FY2022 (+143.2%) and $478,772 in FY2021 (+164.5%).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Stock Comp. (Qtr)
1 Eli Lilly 1,359.75 Bn 1,333.37 Bn 20.46 Bn 200.00 Mn
2 Johnson & Johnson 688.76 Bn 608.62 Bn 17.30 Bn 357.00 Mn
3 AbbVie 521.69 Bn 489.75 Bn 13.12 Bn 160.00 Mn
4 Merck 364.31 Bn 327.31 Bn 13.19 Bn 369.00 Mn
5 Novartis Ag 306.35 Bn 279.93 Bn - -
6 Astrazeneca 285.96 Bn 259.56 Bn 13.26 Bn -
7 Amgen 251.88 Bn 203.53 Bn 7.58 Bn 128.00 Mn
8 Gilead Sciences 208.59 Bn 183.61 Bn 6.73 Bn 234.00 Mn
9 Pfizer 164.73 Bn 112.38 Bn 12.56 Bn 362.00 Mn
10 Kazia Therapeutics 10.72 Mn -41.65 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2020 223,154.39
Dec 31, 2019 138,959.26
Dec 31, 2009 963,489.22
API Access

Kazia Therapeutics Share-based Compensation API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=share-based-compensation&ticker=KZIA&period=max&api_key=YOUR_API_KEY